News

Thursday, 4. March 2010

Company News: Micromet Reports Fourth Quarter and Full Year 2009 Financial Results

Micromet, Inc. (NASDAQ: MITI), a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced its financial results for the fourth quarter and full year ended December 31, 2009. The Company also highlighted recent pipeline progress and outlined expected 2010 milestones.

Further details can be found at: www.micromet-inc.com

Food for Thought: Speedway – A New Electromobility Concept

Food for Thought: Improving Media Coverage on Healthcare